Alzheimer's disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is ...

To manage the finances of CAR-T therapies, which can cost up to $1 million each, health systems are increasingly using “pay for performance” deals, according to a Nov. 17 article in Specialty Pharmacy ...

Researchers said a survey of U.S. adults found 72% say sleepiness sometimes, often or always gets in the way of their ...

Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...

Alzheimer's disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is ...

The FDA will mandate its strictest safety warning on Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy, ...

A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...

A map of the brain reveals how changes in neurons and microglia could explain depression and open the door to more precise ...

JPMorgan downgraded Rocket Pharmaceuticals (RCKT) to Underweight from Neutral without a price target The firm believes Rocket has an “interesting” ...

Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such ...

At the Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs ...

Taysha Gene Therapies Inc. (NASDAQ: TSHA) is a must-buy penny stock to buy now. On November 13, Piper Sandler analyst Biren ...